ozanimod
2 Exciting New FDA Approvals For Ulcerative Colitis Treatment
In this month’s The Regueiro Report, I’d like to highlight two exciting FDA approvals for moderately to ...
APRIL 1, 2024
FDA Approves Zeposia for Treatment of Ulcerative Colitis
The FDA has approved ozanimod (Zeposia, Bristol Myers Squibb) for the treatment of adults with moderately to ...
JUNE 1, 2021
Ozanimod Met Phase 3 Trial End Points for Ulcerative Colitis
Ozanimod, an oral therapy with a unique targeted mechanism of action, was effective for the control of ulcerative ...
MARCH 16, 2021
Load more